Claude Nicaise
Director, Sarepta Therapeutics.
Companies
- FILANA THERAPEUTICS, INC.Board member Dec 8, 2023 to now1
- Chemomab Therapeutics Ltd.Board member Mar 25, 2021 to now2
- Gain Therapeutics, Inc.Board member Mar 17, 2021 to now3
- Sarepta TherapeuticsBoard member Jun 4, 2015 to now4
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sarepta Therapeutics SRPT48,407 shares5$857.5K at $17.71Jun 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 4, 2026Granted 16,875 shares of Sarepta Therapeutics5
- Jan 29, 2026Shares withheld for tax 6,780 shares at $21.23 of Sarepta Therapeutics6
- Jan 29, 2026Exercised options 10,500 shares at $13.71 of Sarepta Therapeutics6
- Mar 12, 2025Sold 2,491 shares at $99.64 of Sarepta Therapeutics7
- Mar 12, 2025Exercised options 9,746 shares at $25.18 of Sarepta Therapeutics7
- Mar 10, 2025Granted 2,383 shares of Sarepta Therapeutics8
- Mar 1, 2024Granted 1,846 shares of Sarepta Therapeutics9
- Mar 6, 2023Granted 1,523 shares of Sarepta Therapeutics10
- Mar 7, 2022Granted 2,953 shares of Sarepta Therapeutics11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARSarepta Therapeutics, Board member
- 5
- 6SEC EDGARForm 4 filed Jan 29, 2026
- 7SEC EDGARForm 4 filed Mar 13, 2025
- 8SEC EDGARForm 4 filed Mar 11, 2025
- 9SEC EDGARForm 4 filed Mar 5, 2024
- 10SEC EDGARForm 4 filed Mar 8, 2023
- 11SEC EDGARForm 4 filed Mar 8, 2022